Publications

Thompson CM, Kawashima H, and Strobel HW. 1998. Isolation of partially purified P450 2D18 and characterization of activity towards the tricyclic antidepressants imipramine and desipramine. Archives of Biochemistry and Biophysics. 359(1), 115–121.

Kuang W, Xu H, Vachon HP, Liu L, Loechel F, Wewer UM, Engvall E. 1998. Merosin-deficient congenital muscular dystrophy; partial genetic correction in two mouse models. J Clin Invest 102(4):844–852.

Rogers JM. 1998. Life stage and its impact on risk of environmentally-induced adverse effects: Introduction. Environ Toxicol Pharmacol 4:299–300.

Keen CL Taubeneck, MW Zidenberg, Cherr S, Daston GP, Rogers JM. 1998. Toxicant exposure and trace element metabolism in pregnancy. Environ Toxicol Pharmacol 4:301–308.

Zucker RM, Hunter S, Rogers JM. 1998. Confocal laser scanning microscopy of apoptosis in organogenesis-stage mouse embryos. Cytometry 33:348–354.

Reeve GR, Pastula S, Rontal R. 1998. A major employer as a health care services laboratory. Int J Qual Health Care 10(6):547–553.

Booth RB, Brown RL, Bucholtz ED, Choksi NY, Owens CE, Wyrick S.D. Phenylaminotetralins: A new class of histamine H1-type ligands that affect catecholamine synthesis and release in vitro and in vivo. Society for Neuroscience Abstracts, 24:1838, 1998

Lea IA, Kurth B, O’Rand MG. 1998. Immune response to immunization with sperm antigens in the macaque oviduct. Biol Reprod 58(3):794–800.

Lea IA, van Lierop MJ, Widgren EE, Grootenhuis A, Wen Y, van Duin M, O’Rand MG. A chimeric sperm peptide induces antibodies and strain-specific reversible infertility in mice. Biol Reprod. 1998 Sep;59(3):527-36. DOI: 10.1095/biolreprod59.3.527

Van Landingham CB, Covington TR, Gearhart JM, Clewell HJ. Evaluation of the uncertainty in the RfD for methylmercury due to interindividual variability in pharmacokinetics. Poster presented at the Society of Toxicology Annual Meeting, Seattle, WA, March 1998.

Clewell HJ, Covington TR, Gearhart JM. Application of a physiologically based pharmacokinetic (PBPK) model for methylmercury (MeHg) in a dose reconstruction of the Iraqi accidental exposures. Poster presented at the Society of Toxicology Annual Meeting, Seattle, WA, March 1998.

Skaggs, Jr. M.M., and M.A. Harris. 1997. Risk management strategies for site closure actions. National Association for Environmental Management. October 1997. Dallas, TX.

Costa M, Zhitkovich A, Harris MA, Paustenbach D, and Gargas M. 1997. DNA-Protein crosslinks produced by various chemicals in cultured human lymphocytes. J Toxicol Environ Health.

Kawashima H, Kusunose E, Thompson CM, and Strobel HW. 1997. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Archives of Biochemistry and Biophysics. 347(1), 148–154.

Pierre HV, Xu H, Liu L, Loechel F, Hayashi Y, Arahata K, et al. 1997. Integrins (a7b1D) in muscle function and survival; disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 100(7):1870–1881.

Scott P, Finley B, Harris MA, Rabbe D. 1997. Determination of background airborne hexavalent chromium concentrations in industrial areas. J Air Waste Manage. Assoc. 47:592-600.

Reeve GR, Pastula ST. The incidence of injuries involving robots in a large manufacturing company. Oral presentation, NIOSH National Occupational Injury Research Symposium, Morgantown, WV, October 1997.

Paustenbach DJ, Panko JM, Fredrick MM, Finley BL, Proctor DM. 1997. Urinary chromium as a biological marker of environmental exposure: What are the limitations? Regul Toxicol Pharmacol 26(1 Pt 2):S23–S34.

Finley BL, Burton S, Panko JM, Proctor DM. 1997. A preliminary assessment of PCB risks to human and ecological health in the lower Passaic River. J Soc Environ Tox Chem 52(2):95–118.

Thompson CM, Bernhard AE, and Strobel HW. 1997. Barbiturate-induced expression of neuronal nitric oxide synthase in the rat cerebellum. Brain Research. 754, 142–146.